<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02144259</url>
  </required_header>
  <id_info>
    <org_study_id>813000</org_study_id>
    <nct_id>NCT02144259</nct_id>
  </id_info>
  <brief_title>The Impact of Contraception on Postpartum Weight Loss</brief_title>
  <acronym>PPWL</acronym>
  <official_title>The Impact of Contraception on Postpartum Weight Loss: a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective mixed methods study to assess weight changes in women randomized to
      receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who
      choose non-hormonal contraception or no contraception immediately postpartum. After
      enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series
      of questions, take a pregnancy test, and be weighed. Total length of participation for each
      subject is 1 year or until pregnancy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight</measure>
    <time_frame>6 months from postpartum (baseline)</time_frame>
    <description>Weight will be measured at 6 months postpartum. Percent weight change will be compared amongst the groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy Rate</measure>
    <time_frame>1 year</time_frame>
    <description>The secondary outcome variable is pregnancy rate. Pregnancy testing will occur at 3, 6 and 12 months postpartum or at any time that a participant felt that she might be pregnant.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Contraceptive Satisfaction</measure>
    <time_frame>1 year</time_frame>
    <description>Satisfaction will be measured in response to the question, &quot;How satisfied are you with your current birth control method?&quot; This question will be asked to the participant at the 6 month follow-up visit. Answer choices that participants could choose from range from &quot;Very Good&quot; to &quot;Very Poor&quot;. &quot;Good&quot; or &quot;Very Good&quot; responses will be analyzed as having been satisfied with the method.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Weight</condition>
  <arm_group>
    <arm_group_label>DMPA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Implanon group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to receive Implanon immediately post-partum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects selecting their own method of contraception or no contraception.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DMPA immediately postpartum</intervention_name>
    <description>DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
    <arm_group_label>DMPA group</arm_group_label>
    <other_name>DepoProvera, depot medroxyprogesterone acetate (DMPA)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Implanon immediately postpartum</intervention_name>
    <description>Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
    <arm_group_label>Implanon group</arm_group_label>
    <other_name>etonogestrel implant</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

          -  Aged 18-45 at enrollment (inclusive)

          -  Immediately postpartum of a live singleton infant, 37 weeks gestation, at HUP

          -  Desiring to delay another pregnancy for 6 months

          -  Willing and able to follow the study protocol

        Exclusion Criteria:

          -  Breastfeeding during study participation

          -  Plans for relocation outside of Philadelphia in the next six months

          -  Plans for use of weight loss medication or diet pills in the next six months

          -  Women who wish to start Implanon ® or DMPA prior to discharge but who do not want to
             be randomized. 5. Issues or concerns in the judgment of the investigator that may
             compromise the safety of the subject or confound the reliability of compliance and
             information acquired in this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Courtney A Schreiber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2014</study_first_submitted>
  <study_first_submitted_qc>May 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2014</study_first_posted>
  <results_first_submitted>December 19, 2014</results_first_submitted>
  <results_first_submitted_qc>December 23, 2016</results_first_submitted_qc>
  <results_first_posted type="Actual">February 17, 2017</results_first_posted>
  <last_update_submitted>December 23, 2016</last_update_submitted>
  <last_update_submitted_qc>December 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Medroxyprogesterone</mesh_term>
    <mesh_term>Medroxyprogesterone Acetate</mesh_term>
    <mesh_term>Etonogestrel</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>DMPA Group</title>
          <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum: DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
        </group>
        <group group_id="P2">
          <title>Implanon Group</title>
          <description>Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum: Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
        </group>
        <group group_id="P3">
          <title>Control Group</title>
          <description>Subjects selecting their own method of contraception or no contraception.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
                <participants group_id="P3" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DMPA Group</title>
          <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum: DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
        </group>
        <group group_id="B2">
          <title>Implanon Group</title>
          <description>Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum: Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
        </group>
        <group group_id="B3">
          <title>Control Group</title>
          <description>Subjects selecting their own method of contraception or no contraception.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="34"/>
            <count group_id="B4" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.06" spread="4.68"/>
                    <measurement group_id="B2" value="22.42" spread="3.81"/>
                    <measurement group_id="B3" value="26.59" spread="5.42"/>
                    <measurement group_id="B4" value="24.02" spread="4.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weight</title>
        <description>Weight will be measured at 6 months postpartum. Percent weight change will be compared amongst the groups</description>
        <time_frame>6 months from postpartum (baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DMPA Group</title>
            <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum: DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
          </group>
          <group group_id="O2">
            <title>Implanon Group</title>
            <description>Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum: Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
          </group>
          <group group_id="O3">
            <title>Control Group</title>
            <description>Subjects selecting their own method of contraception or no contraception.</description>
          </group>
        </group_list>
        <measure>
          <title>Weight</title>
          <description>Weight will be measured at 6 months postpartum. Percent weight change will be compared amongst the groups</description>
          <units>percent weight lost</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="9.1"/>
                    <measurement group_id="O2" value="6.8" spread="8.1"/>
                    <measurement group_id="O3" value="7.0" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Because the expected amount of postpartum weight loss in non-breastfeeding women is not documented in the literature, we chose a sample size that would enable us to detect a one standard deviation difference in weight loss between the 3 groups at the primary 6 month endpoint. We used generalized estimating equations (GEEs) to test differences among all 3 groups over all the study periods.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>GEE</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pregnancy Rate</title>
        <description>The secondary outcome variable is pregnancy rate. Pregnancy testing will occur at 3, 6 and 12 months postpartum or at any time that a participant felt that she might be pregnant.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DMPA Group</title>
            <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum: DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
          </group>
          <group group_id="O2">
            <title>Implanon Group</title>
            <description>Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum: Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
          </group>
          <group group_id="O3">
            <title>Control Group</title>
            <description>Subjects selecting their own method of contraception or no contraception.</description>
          </group>
        </group_list>
        <measure>
          <title>Pregnancy Rate</title>
          <description>The secondary outcome variable is pregnancy rate. Pregnancy testing will occur at 3, 6 and 12 months postpartum or at any time that a participant felt that she might be pregnant.</description>
          <units>number of pregnancies</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Contraceptive Satisfaction</title>
        <description>Satisfaction will be measured in response to the question, &quot;How satisfied are you with your current birth control method?&quot; This question will be asked to the participant at the 6 month follow-up visit. Answer choices that participants could choose from range from &quot;Very Good&quot; to &quot;Very Poor&quot;. &quot;Good&quot; or &quot;Very Good&quot; responses will be analyzed as having been satisfied with the method.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DMPA Group</title>
            <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum: DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
          </group>
          <group group_id="O2">
            <title>Implanon Group</title>
            <description>Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum: Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
          </group>
          <group group_id="O3">
            <title>Control Group</title>
            <description>Subjects selecting their own method of contraception or no contraception.</description>
          </group>
        </group_list>
        <measure>
          <title>Contraceptive Satisfaction</title>
          <description>Satisfaction will be measured in response to the question, &quot;How satisfied are you with your current birth control method?&quot; This question will be asked to the participant at the 6 month follow-up visit. Answer choices that participants could choose from range from &quot;Very Good&quot; to &quot;Very Poor&quot;. &quot;Good&quot; or &quot;Very Good&quot; responses will be analyzed as having been satisfied with the method.</description>
          <units>percentage of women satisfied w. method</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="89"/>
                    <measurement group_id="O3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>DMPA Group</title>
          <description>Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum: DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.</description>
        </group>
        <group group_id="E2">
          <title>Implanon Group</title>
          <description>Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum: Implanon ® is a subdermal implant that contains 68mg of etonogestrel.</description>
        </group>
        <group group_id="E3">
          <title>Control Group</title>
          <description>Subjects selecting their own method of contraception or no contraception.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>First, we chose to exclude nursing women. Second, we had a small sample with power to detect one standard deviation difference in weight loss. Third, all data were collected prospectively,thus we did not have each participant’s pre-pregnancy weight.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Courtney Schreiber</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>215-615-5234</phone>
      <email>courtney.schreiber@uphs.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

